{"DataElement":{"publicId":"7197399","version":"1","preferredName":"Subcategory for Immunogenicity Test","preferredDefinition":"A sub-division of the ISCAT values based on sponsor defined characteristics.","longName":"IS_ISSCAT_SPD","context":"NRDS","contextVersion":"1","DataElementConcept":{"publicId":"6640967","version":"1","preferredName":"Immunogenicity Specimen Assessments Domain Immunogenicity Specimen Assessments Subcategory","preferredDefinition":"A findings about domain for submitting dermal responses to antigens._A subdivision of immunogenicity specimen assessments.","longName":"6607820v1.0:6640965v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6607820","version":"1","preferredName":"Immunogenicity Specimen Assessments Domain","preferredDefinition":"A findings about domain for submitting dermal responses to antigens.","longName":"C112320","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunogenicity Specimen Assessments Domain","conceptCode":"C112320","definition":"A findings about domain for submitting dermal responses to antigens.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F1CAA73-854C-445C-E053-F662850A4547","latestVersionIndicator":"Yes","beginDate":"2019-01-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-10","modifiedBy":"ONEDATA","dateModified":"2019-01-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6640965","version":"1","preferredName":"Immunogenicity Specimen Assessments Subcategory","preferredDefinition":"A subdivision of immunogenicity specimen assessments.","longName":"C117558","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunogenicity Specimen Assessments Subcategory","conceptCode":"C117558","definition":"A subdivision of immunogenicity specimen assessments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"81B44049-C836-7C1D-E053-F662850A7C09","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-12","modifiedBy":"ONEDATA","dateModified":"2019-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"81B44049-C847-7C1D-E053-F662850A7C09","latestVersionIndicator":"Yes","beginDate":"2019-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-02-12","modifiedBy":"RAGUNATHANU","dateModified":"2023-06-08","changeDescription":"2/12/19 Curated to support CDISC Initiative; tmt.","administrativeNotes":"06/08/2023: Released upon completion of review. UR07.14.22_Released as part of the quarterly metrics and per request by G.Riley_07.14.22","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7185338","version":"1","preferredName":"Immunogenicity Specimen Assessments Subcategory Clinical Study Sponsor Defined Type","preferredDefinition":"A subdivision of immunogenicity specimen assessments._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._Something distinguishable as an identifiable class based on common qualities.","longName":"ISSCAT_SPD","context":"NRDS","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"OTHER","valueDescription":"Other","ValueMeaning":{"publicId":"5697874","version":"1","preferredName":"Other","longName":"5697874","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4A253837-4DE2-5542-E053-F662850A338C","latestVersionIndicator":"Yes","beginDate":"2017-03-07","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-03-07","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9F7FCA67-E9C2-5DBF-E053-F662850A170F","beginDate":"2020-02-12","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-26","modifiedBy":"ONEDATA","dateModified":"2020-02-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7185337","version":"1","preferredName":"Immunogenicity Specimen Assessments Subcategory Clinical Study Sponsor Defined Type","preferredDefinition":"A subdivision of immunogenicity specimen assessments.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:Something distinguishable as an identifiable class based on common qualities.","longName":"C117558:C70793:C165683:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunogenicity Specimen Assessments Subcategory","conceptCode":"C117558","definition":"A subdivision of immunogenicity specimen assessments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F7FCA67-E99B-5DBF-E053-F662850A170F","latestVersionIndicator":"Yes","beginDate":"2020-02-26","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-02-26","modifiedBy":"ONEDATA","dateModified":"2020-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9F7FCA67-E9AC-5DBF-E053-F662850A170F","latestVersionIndicator":"Yes","beginDate":"2020-02-26","endDate":"2022-07-12","createdBy":"TAYLORT","dateCreated":"2020-02-26","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"2/26/20 Created to support sponsor defined codelists; tmt.","administrativeNotes":"07.14.22_Released during quarterly metrics and per request from G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"7066596","version":"1","longName":"CDISC (NRDS Implementation)","context":"NRDS"},{"publicId":"7067375","version":"1","longName":"Sponsor Defined","context":"NRDS"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Data Element Subcategory for Immunogenicity Test does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Subcategory for Immunogenicity Test does not have Preferred Question Text","url":null,"context":"NRDS"},{"name":"Permissible","type":"SDTM Core","description":"Permissible","url":null,"context":"NRDS"},{"name":"CDISC Notes","type":"CDISC Note","description":"A further categorization of ISCAT.","url":null,"context":"NRDS"}],"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A080F0D6-EC10-0381-E053-F662850AB7A1","latestVersionIndicator":"Yes","beginDate":"2020-03-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-03-10","modifiedBy":"GDEEN","dateModified":"2022-07-14","changeDescription":"3-10-20 Created to support sponsor defined codelists; tmt.","administrativeNotes":"07.14.22_Released as part of the quarterly metrics and per request of G. Riley_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}